Why BofA remains cautious on Intel stock despite ongoing rally

Bank of America raised its Intel price target to $96 from $56, but kept an Underperform rating, saying a potential Apple foundry deal is already largely priced in. The bank estimates the deal could eventually add about $10 billion in annual foundry sales by 2030, but said it would take 2-3 years of investment and qualification before meaningful revenue, with breakeven possibly slipping beyond 2027. Intel shares jumped 14% to a record close of $124.92, even as BofA argued AMD and ARM remain better positioned to benefit from rising server CPU demand.

Analysis

The market is pricing Intel less like a cyclical turnaround and more like a credible second-sourcing option for the highest-end consumer silicon stack. That creates a subtle but important spread trade: Intel can monetize the narrative well before it monetizes the cash flow, while Apple buys optionality without near-term dependency risk. In other words, the equity can keep rerating on strategic relevance even if foundry economics remain mediocre for several years.

The bigger second-order effect is competitive pressure on the ARM ecosystem rather than just on Intel’s own earnings. If Apple meaningfully diversifies manufacturing, it reduces the perceived structural moat of the existing fabless manufacturing chain and forces AMD/ARM to compete not only on performance but on supply-chain resilience and geopolitical optionality. That is a slow-burn headwind for the peer set because the market tends to pay up for franchises that look less exposed to single-node or single-foundry concentration.

The near-term setup is still asymmetric for volatility, not fundamentals: the stock has already discounted a lot of the strategic narrative, but the next two catalysts are binary and long-dated — deal confirmation and any indication of Apple silicon qualification scope. The real bear case is not “no deal,” but “deal announced, economics weak, ramp delays, and margin dilution persists,” which could compress the multiple once the headline premium fades. On the upside, any evidence that Intel can qualify more advanced products faster than expected would force a further squeeze, but that is a multi-quarter story, not a one-day trade.

Consensus may be underestimating how much of this is a sentiment trade on Intel versus a valuation problem for beneficiaries that have been treated as structural winners. If Apple shifts even a portion of chip production, it does not automatically validate Intel’s foundry model; it may simply validate Apple’s bargaining power and expose how much of the value accrues to the customer, not the manufacturer. That argues for favoring relative-value expressions over outright longs in Intel.

Key Decisions for Investors

• Short INTC into strength or via call spreads over the next 1-3 months: the stock has likely front-loaded the strategic upside, while the earnings and margin contribution from any Apple-related business is still years away.
• Pair trade: long AAPL / short INTC for 3-6 months if the market keeps extrapolating the foundry story; Apple gets optionality and supply-chain diversification without meaningful execution risk, while Intel carries the capex and yield risk.
• Relative short: long AMD vs. short INTC for 6-12 months if server TAM optimism persists; AMD is a cleaner lever to share gains in a rising market without the dilution from foundry buildout.
• Buy downside protection on INTC with 6-12 month puts or put spreads after any post-news rally extension; the key risk is a headline fade once investors refocus on cash burn, depreciation, and delayed breakeven.
• If seeking a tactical long, use a small size momentum trade only on confirmed deal headlines and exit into the announcement gap; risk/reward deteriorates quickly once the market shifts from speculation to execution scrutiny.